REPLIMUNE GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.41 USD | -4.75% |
|
-7.77% | -23.96% |
| Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
| Mar. 26 | Replimune Group, Inc. Announces Management Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REPLIMUNE GROUP, INC. | Other Biotechnology & Medical Research | -4.75% | -7.77% | -23.96% | -66.79% | -58.65% | 393M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- REPL Stock
- Charts Replimune Group, Inc.
- Comparison Chart